The technology of the devices is based on research by the Max Planck Institute for Extraterrestrial Physics under Prof. Dr. dr h.c. Gregor Morfill (CTO terraplasma GmbH). In order to help as many patients as possible with problematic or complex wounds and to ensure widespread use in clinics and care facilities, plasma care® will be distributed by Viromed GmbH in the future.
In addition to the bactericidal and healing-promoting effect, cold plasma therapy in wound care offers strong advantages for the healthcare system, including a reduction in nursing costs, shorter hospital stays and an improved quality of life for the patients.
